[Antithrombotic prevention and therapy in coronary heart disease].
Bode
C
C
Medizinische Klinik III (Kardiologie, Angiologie, Pulmologie), Ruprecht-Karls Universität Heidelberg.
Kohler
B
B
Moser
M
M
Zimmermann
R
R
Strasser
R H
RH
Kübler
W
W
D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003328:Coronary Thrombosis / Q000097:blood / Q000517:prevention & control*; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects
D005343:Fibrinolytic Agents; D001241:Aspirin